Stock Groups

Countries respond to heart inflammation risk from mRNA shots By Reuters

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – Vials with Pfizer BioNTech and Moderna Coronavirus Disease (COVID-19), vaccine labels can be seen in this illustration taken on March 19, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters] Several countries have stopped giving COVID shots based in mRNA technology to teenagers or given only one dose. This is after reports that there may be rare cardiac side effects.

Europe’s drug regulator stated in July that it found possible links between rare conditions of the heart and COVID-19 vaccines by Pfizer/BioNTech. Moderna (NASDAQ:)

However, the World Health Organization and European regulators have stated that the benefits of mRNA injections in COVID-19 prevention continue to outweigh any risks.

These are the steps taken by some countries:

CANADA

Canada’s Public Health Agency said that data suggests that reports of rare heart disease were greater after Moderna’s COVID-19 vaccine than they were following the Pfizer/BioNTech shots.

SWEDEN

Sweden has stopped using Moderna’s COVID-19 vaccination for young people, citing unpublished data from the Nordic study.

Swedish health agencies announced that they would stop using vaccines for children born between 1991 and 2002, as there were data showing an increase in myocarditis (and pericarditis) among young people and adults who have been vaccinated.

DENMARK

Denmark

On Friday, the Danish Health Agency stated that Moderna’s COVID-19 vaccine was being offered to children under 18 years old. A Wednesday statement suggesting that there had been a suspension of service was misinterpreted.

FINLAND

Finland has stopped using Moderna vaccines in younger persons and will instead give Pfizer (NYSE:) The first vaccine for men born between 1991 and 2002. This vaccine is available to all ages 12 years and older.

HONG KONG

Following reports that heart inflammation may be a side effect, the panel of Hong Kong’s health experts recommended that all children aged 12-17 receive only one dose BioNTech COVID-19 vaccine.

NORWAY

Norway has given one dose Pfizer/BioNTech vaccination to 12-15-year-olds.

UNITED KINGDOM

All 12-15 year-olds in Britain have been offered a free shot of BioNTech/Pfizer vaccine. The second dose would not be given to this age group until spring, when more information may become available from the rest of the world.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]